203 related articles for article (PubMed ID: 37688712)
41. Methadone as First-line Opioid for the Management of Cancer Pain.
Mercadante S; Adile C; Ferrera P; Pallotti MC; Ricci M; Bonanno G; Casuccio A
Oncologist; 2022 Apr; 27(4):323-327. PubMed ID: 35380722
[TBL] [Abstract][Full Text] [Related]
42. Intravenous Methadone for Perioperative and Chronic Cancer Pain: A Review of the Literature.
Mercadante S
Drugs; 2023 Jul; 83(10):865-871. PubMed ID: 37308798
[TBL] [Abstract][Full Text] [Related]
43. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
[TBL] [Abstract][Full Text] [Related]
44. Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.
Ulker E; Del Fabbro E
Oncologist; 2020 Mar; 25(3):189-196. PubMed ID: 31872911
[TBL] [Abstract][Full Text] [Related]
45. Methadone switching for refractory cancer pain.
Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
BMC Palliat Care; 2022 Nov; 21(1):191. PubMed ID: 36324113
[TBL] [Abstract][Full Text] [Related]
46. Methadone for Cancer Pain in Pediatric End-of-Life Care.
Hall EA; Sauer HE; Habashy C; Anghelescu DL
Am J Hosp Palliat Care; 2021 Aug; 38(8):914-919. PubMed ID: 33000633
[TBL] [Abstract][Full Text] [Related]
47. Opioid switch to oral methadone in cancer pain.
Mancini I; Lossignol DA; Body JJ
Curr Opin Oncol; 2000 Jul; 12(4):308-13. PubMed ID: 10888415
[TBL] [Abstract][Full Text] [Related]
48. Practicability, safety, and efficacy of a "German model" for opioid conversion to oral levo-methadone.
Ostgathe C; Voltz R; Van Aaaken A; Klein C; Sabatowski R; Nauck F; Gaertner J
Support Care Cancer; 2012 Sep; 20(9):2105-10. PubMed ID: 22130587
[TBL] [Abstract][Full Text] [Related]
49. Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time.
Tanaka R; Ishikawa H; Sato T; Shino M; Matsumoto T; Mori K; Omae K; Osaka I
Am J Hosp Palliat Care; 2017 Jul; 34(6):572-576. PubMed ID: 27034433
[TBL] [Abstract][Full Text] [Related]
50. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
Moryl N; Kogan M; Comfort C; Obbens E
Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
[TBL] [Abstract][Full Text] [Related]
51. Factors Associated with Improvement in Uncontrolled Cancer Pain without Increasing the Opioid Daily Dose among Patients Seen by an Inpatient Palliative Care Team.
Qian Y; Haider A; Lu Z; Naqvi S; Zhuang A; Nguyen K; Reddy A; Arthur J; Tanco K; Williams J; Wu J; Liu D; Naberhuis J; Bruera E
J Palliat Med; 2020 Apr; 23(4):483-488. PubMed ID: 31687882
[No Abstract] [Full Text] [Related]
52. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
53. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
54. [Use of methadone for support of oncological treatment? : Statement of the working group on tumor pain of the German Pain Society].
Hofbauer H; Schenk M; Kieselbach K; Wirz S
Schmerz; 2017 Feb; 31(1):2-4. PubMed ID: 28044195
[No Abstract] [Full Text] [Related]
55. Association of polymorphisms in
Ozberk D; Haywood A; Sutherland HG; Yu C; Albury CL; Zunk M; George R; Good P; Griffiths LR; Hardy J; Haupt LM
Pharmacogenomics; 2022 Apr; 23(5):281-289. PubMed ID: 35189719
[No Abstract] [Full Text] [Related]
56. Switching to Intravenous Methadone in Advanced Cancer Patients: A Retrospective Analysis.
Mercadante S; Cascio AL; Casuccio A
J Pain Symptom Manage; 2023 Oct; 66(4):287-292. PubMed ID: 37236430
[TBL] [Abstract][Full Text] [Related]
57. Safety aspects of opioid-naïve patients with high-grade glioma treated with D,L-Methadone: an observational case series.
von der Brelie C; Schatlo B; Bettag C; Rohde V
Neurosurg Rev; 2021 Feb; 44(1):579-586. PubMed ID: 32060760
[TBL] [Abstract][Full Text] [Related]
58. Managing Pain in Patients and Survivors: Challenges Within the United States Opioid Crisis.
Paice JA
J Natl Compr Canc Netw; 2019 May; 17(5.5):595-598. PubMed ID: 31117028
[TBL] [Abstract][Full Text] [Related]
59. Clinical pharmacology of methadone for pain.
Fredheim OM; Moksnes K; Borchgrevink PC; Kaasa S; Dale O
Acta Anaesthesiol Scand; 2008 Aug; 52(7):879-89. PubMed ID: 18331375
[TBL] [Abstract][Full Text] [Related]
60. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
